Acalabrutinib and Obinutuzumab for the Treatment of Previously Untreated Follicular Lymphoma or Other Indolent Non-Hodgkin Lymphomas
Clinical trial NCT04883437 · RECRUITING
Trial details
- NCT number
- NCT04883437
- Sponsor
- Emory University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-03
- Primary completion
- 2026-09-23
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.